Glenmark Pharmaceuticals

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue3,2916,2483,9453,9604,084
Expenses2,8723,8953,2273,1993,441
EBITDA606.972,560914.22951.68870.56
Operating Profit153.811,034575.43430.37697.39
Profit Before Tax95.58967.40534.00387.77643.39
Net Profit46.97610.43403.23301.32482.83
Financial Ratios
Operating Profit Margin9.27%19.57%18.77%15.38%22.14%
Net Profit Margin8.52%25.57%13.89%14.96%12.28%
Earning Per Share (Diluted)1.6621.6214.2810.6817.11
Dividends Per Share0.000.000.000.000.00